Form D · Biotechnology
ARTERICA INC.
Santa Rosa, CA · CIK 0001782224
Offering snapshot reported May 17, 2023 · SEC filing
- Reported sold
- $2.5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 12, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 17, 2023 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Oct 26, 2021 | Initial | $805,000 | No comparison | 10 | SEC filing |
| Jul 11, 2019 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481989
Up to $5,000,000 in Convertible Promissory Notes and underlying shares of common stock upon conversion.
Source: Form D, filed May 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Humphrey | Executive |
| Thomas Larzon | Director |
| Charlie Rampersaud | Director |
| Thorsten Siess | Director |
| Tobias Tullberg | Director |
| Tobias Tullbert | Director |
| Robert Whirley | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3617 Westwind Blvd
Santa Rosa, CA, 95403
Santa Rosa, CA, 95403